Brief Blog: Quest Acquires PathAI Diagnostics Service

According to a May 1, 2024, press release, Quest Diagnostics will acquire PathAI Diagnostics to advance AI and digital pathology in cancer diagnostics. This acquisition includes a licensing agreement for PathAI’s AISight™ digital pathology image management system. 

Per the press release, Quest aims to enhance diagnostic quality, speed, and cost efficiency by integrating PathAI's AI technologies with its oncology expertise. The collaboration will involve Quest's Memphis lab into an AI and digital R&D center, supporting the specialized pathology services while extending digital pathology benefits to a wider network.

Find the full press release here:

https://www.pathai.com/resources/quest-diagnostics-acquire-pathai-diagnostics/

##

PathAI raised $165M in May 2021.

##

See also an April press release about PathAI and Hoag Health System:

https://www.pathai.com/resources/hoag-health-system-selects-pathai-and-the-aisight-image-management-system-to-support-the-transition-to-digital-and-ai-enabled-pathology/

See also an April press release about PathAI and Google Cloud-driven drug discovery services:

https://www.pathai.com/resources/pathai-partners-with-google-cloud-to-transform-drug-discovery-and-precision-medicine-through-ai-powered-pathology/

____________

AI Corner

Press release summary by GPT4; reviewed.